Show simple item record

dc.contributor.authorGuo, C
dc.contributor.authorBanerji, U
dc.date.accessioned2021-05-14T08:17:09Z
dc.date.available2021-05-14T08:17:09Z
dc.date.issued2021-08-31
dc.identifier.citationBritish journal of cancer, 2021
dc.identifier.issn0007-0920
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4554
dc.identifier.eissn1532-1827
dc.identifier.doi10.1038/s41416-021-01357-2
dc.description.abstractKRAS mutations drive a wide variety of cancers. Drugs targeting the protein product of KRASG12C mutations are currently being evaluated show preliminary efficacy in clinical trials. A clinical trial of VS-6766, a dual RAF-MEK inhibitor, has reported early single agent activity in non-G12C mutated KRAS driven cancers.
dc.formatPrint-Electronic
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGERNATURE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleSearching for treatments for non-G12C-KRAS mutant cancers.
dc.typeJournal Article
dcterms.dateAccepted2021-03-11
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1038/s41416-021-01357-2
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-04-15
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBritish journal of cancer
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Pharmacology – Adaptive Therapy
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Pharmacology – Adaptive Therapy
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamClinical Pharmacology – Adaptive Therapy
icr.researchteamClinical Pharmacology – Adaptive Therapy
dc.contributor.icrauthorGuo, Wei Yu
dc.contributor.icrauthorBanerji, Udai


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0